Magneto-Optical Detection of the Orbital Hall Effect in Chromium
Physical Review Letters · 11.10.2023 · 131 (15)
DOI: 10.1103/physrevlett.131.156702 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physical Review Letters, online erschienen am 11.10.2023. Verfasst von Igor Lyalin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physics, The Ohio State University, Columbus, Ohio 43210, USA. Die Arbeit wurde bisher 199-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Science Foundation, Materials Research Science and Engineering Center, Harvard University, Vetenskapsrådet.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Physics, The Ohio State University, Columbus, Ohio 43210, USA.
- Department of Physics and Astronomy, Uppsala University, P.O. Box 516, SE-75120 Uppsala, Sweden.
- Department of Physics and Astronomy, University of Exeter, Stocker Road, Exeter EX4 4QL, United Kingdom.
Förderung
- National Science Foundation
- Materials Research Science and Engineering Center, Harvard University
- Vetenskapsrådet
- Knut och Alice Wallenbergs Stiftelse
- Swedish National Infrastructure for Computing
- Wallenberg Initiative Materials Science for Sustainability
Zitieren
APA
Lyalin, I., Alikhah, S., Berritta, M., Oppeneer, P. M., & Kawakami, R. K. (2023). Magneto-Optical Detection of the Orbital Hall Effect in Chromium. Physical Review Letters, 131(15). https://doi.org/10.1103/physrevlett.131.156702
Vancouver
Lyalin I, Alikhah S, Berritta M, Oppeneer PM, Kawakami RK. Magneto-Optical Detection of the Orbital Hall Effect in Chromium. Physical Review Letters. 2023;131(15). doi:10.1103/physrevlett.131.156702
BibTeX
@article{Lyalin2023,
author = {Lyalin, Igor and Alikhah, Sanaz and Berritta, Marco and Oppeneer, Peter M and Kawakami, Roland K},
title = {Magneto-Optical Detection of the Orbital Hall Effect in Chromium},
journal = {Physical Review Letters},
year = {2023},
volume = {131},
number = {15},
doi = {10.1103/physrevlett.131.156702}
}
EUVIMED